What Everyone Already Knows
The vet still recommends the medicine. That part has not changed. What has changed is where the pet owner buys it. And for most commercial teams in companion animal health, the pricing, the messaging, and the field plan were all built for a world where the answer was always: at the clinic.
That world is shrinking. Not gone. Shrinking. The question is how fast, and where.
The Shift Is Not Happening at the Same Speed Everywhere
This is the part most portfolio planning misses. The move from clinic dispensing to online pharmacies and direct channels is real, but it is uneven. It runs at different speeds depending on what the product does and how the pet owner uses it.
Chronic medications move fastest. If a pet owner refills the same product every month, they will find a more convenient way to do it. Parasiticide prevention, bought on a subscription cadence, follows the same logic. A leading online prescription pharmacy now anchors two of the most recognized parasiticide brands as primary destinations, with subscription discounts that make the clinic price look hard to justify. That is a structural shift, not a temporary pricing anomaly.
Acute in-clinic treatments move slowest. If the pet owner is in the exam room and the vet is treating a problem right now, the product goes home in a bag. The channel question barely applies.
Everything else sits somewhere in between, and you have to place each product honestly on that spectrum. One plan for the whole portfolio is not a plan. It is an assumption.
What This Does to Detailing
When a pet owner fills the prescription somewhere other than the clinic, the rep visit still matters, but it buys something different. The vet still has to recommend the product. That part of the equation does not change. But the clinic is no longer the point of sale, so stocking and margin arguments do not move the needle the way they used to.
The detail conversation shifts. It becomes about clinical confidence, about why this product is the right call for this patient, about what the pet owner will find when they go looking online. The vet needs to feel good about the recommendation even when the dispensing fee does not follow it.
This is where The Prescriber-to-Pet-Owner Power Shift creates real field execution risk. A team running the old conversation in a clinic that no longer captures the dispensing revenue is leaving the rep without a compelling reason for the clinic to engage. The Rep Journey Planner tool on VetLaunchLab.com is built for exactly this problem. It turns the commercial plan into a concrete sequence for the field, so the first three calls reflect the channel reality of each product, not a generic launch script.
Two Different Jobs, Depending on Where the Pet Owner Buys
Once you have placed each product on the channel spectrum, the commercial job becomes clearer.
Where pet owners buy online, your job is to earn the side-by-side choice. The pet owner is looking at two or three options. The vet recommended yours. Now the pet owner is comparing. Price matters. Availability matters. The subscription option matters. Your online presence has to close what the vet visit opened.
Where the clinic still dispenses, your job is to keep the product worth stocking. That means the clinic sees value in carrying it, the team can talk about it, and the pet owner does not leave with a recommendation and then shop elsewhere. This is a clinic experience question as much as a pricing question.
These are two different commercial motions. Running the same one for every product in the portfolio is what creates the quiet revenue leak that shows up in the quarterly business review and is hard to explain cleanly.
What This Looks Like in a Business Review
Q2 2026 earnings disclosures from major companion animal health companies are arriving now. Commercial teams are building their business reviews for leadership. If the channel mix question is not in the review, the numbers will not make sense. Volume may be holding. Clinic sales may be softening. The gap between the two is the shift.
A good business review names that gap directly. It does not bury it. The Business Review Template and the AI drafting guidance on VetLaunchLab.com both reflect this: the hard number goes on the table before someone else names it, and the response plan follows immediately. The channel shift belongs in that section, named by product, not averaged across the portfolio.
Where to Start
Pick one product from your portfolio that has a chronic use pattern. Map where the pet owner actually fills it today versus twelve months ago. That single exercise will tell you whether your current field plan and your current pricing are still aimed at the right target.
If you want to go further, try the Rep Journey Planner on VetLaunchLab.com to rebuild the field sequence around what the clinic conversation actually needs to accomplish now. Or open the live dashboard for the specific channel signals that are moving this week. The weekly brief covers what is shifting and what it means for commercial teams in companion animal health.